A clinical case of synchronous endometrial and ovarian cancer associated with pregnancy

According to various literature sources, in the general population of women with synchronous endometrial cancer and ovarian cancer is quite rare. We have not found a single foreign or domestic literary source describing clinical cases of primary multiple malignant tumors: synchronous endometrial cancer and ovarian cancer associated with pregnancy.

We present an interesting clinical example that clearly demonstrates the possibility of successful treatment of this variant of primary multiple malignant tumors – synchronous endometrial cancer and ovarian cancer associated with pregnancy. The features of the course of the disease, the features and difficulties of treatment of this pathology are shown. And also the high efficiency of the treatment was shown according to the morphological study with an assessment of the drug pathomorphosis according to Lavnikova.

A case of successful combined treatment is presented, taking into account the combined pathology. According to the received data, it is possible to conclude. The management of pregnant women and the treatment of cancer should be carried out in specialized centers with experience in the treatment of oncological diseases associated with pregnancy.

1. Lee Y.Y., Roberts C.L., Dobbins T. et al. Incidence and outcomes of pregnancy-associated cancer in Australia, 1994–2008: a population-based linkage study. Br J Obstet Gynaecol 2012;119:1572–82.

2. Li W.Q., Cho E., Weinstock M.A. et al. Epidemiological assessments of skin outcomes in the nurses’ health studies. Am J Public Health 2016;106(9):1677–83. DOI: 10.2105/AJPH.2016.303315

3. World Health Organization (WHO): Electronic Journal. Available at: http://www.who.int/topics/en. (In Russ.)

4. The stаte of oncologicаl cаre to the populаtion of Russiа in 2021. Ed. by А.D. Kаprin, V.V. Stаrinskiy, А.O. Shаkhzаdovа. Moscow: P. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia, 2022. 239 p. (In Russ.)

5. Nijman T.A.J., Schutter E.M., Amant F. Sentinel node procedure in vulvar carcinoma during pregnancy: a case report. Gynecol Oncol Case Rep 2012;2:63, 64.

6. Chernyshova A.L., Kolomiets L.A., Sinilkin I.G. et al. Optimization of the extent of surgery in organpreserving treatment for invasive cervical cancer (the role of sentinel lymph nodes study). Voprosy Onkologii 2016;62(6):807–11.

7. Kondakova I.V., Spirina L.V., Koval V.D. et al. Chymotrypsin-like activity and subunit composition of proteasomes in human cancer. Molecular Biology 2014;48(3):384–9.

8. John L., Cowey C.L. The rapid emergence of novel therapeutics in advanced malignant melanoma. Dermatol Ther (Heidelb) 2015;5:151–69.

9. Spirina L.V., Bochkareva N.V., Kondakova I.V. et al. Regulation of insulin-like growth of the NF-kB proteasome system in endometrial cancer. Molekylarnaya biologiya = Molecular Biology 2012;(46):407–13. (In Russ.). DOI: 10.1134/S0026893312020173

10. Spirina L.V., Kondakova I.V., Kolomiets L.A. et al. Activity of proteasomes and their subunit composition in hyperplastic processes and endometrial cancer. Opukholi zhenskoy reproduktivnoy sistemy = Tumors of the female reproductive system 2011;(4):64–8. (In Russ.)

11. Bochkareva N.V., Kolomiets L.A., Chernyshova A.L. Do patients with hyperplastic processes and endometrial cancer need rehabilitation against the background of metabolic syndrome? Sibirskiy onologicheskiy zhurnal = Siberian oncological journal 2010;(5):71–7.

12. Yunusova N.V., Kondakova I.V., Kolomiets L.A. et al. Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors). Asia-Pacific J Clin Oncol 2018;14(3):134–40. DOI: 10.1111/ajco.12780